Shannon B. Peleg, BA

a:1:{i:0;s:56:"New York State Psychiatric Institute, New York, New York";}

JCP
Administering Semaglutide With Long-Term Olanzapine Use
Case Report

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe